Evidence check: VKORC1 in the context of Abnehmen

VKORC1 encodes the vitamin K epoxide reductase complex subunit 1, a key enzyme in vitamin K recycling. Its primary clinical relevance is pharmacogenetic: variants strongly influence warfarin (Coumadin) dose requirements. There is no credible scientific evidence linking VKORC1 directly to weight loss. No well-designed studies have demonstrated that VKORC1 polymorphisms affect basal metabolic rate, fat oxidation, or body composition changes. Some indirect mechanistic speculation exists – vitamin K may modulate adiponectin or insulin sensitivity – but these associations are weak, inconsistent, and not actionable for weight management. In nutrigenetic panels, VKORC1 is included almost exclusively for drug response, not for dietary or weight-loss guidance. Consumers who see VKORC1 in a DNA test marketed for weight loss should be skeptical: the gene has no validated role in energy balance or adiposity. Any claim linking VKORC1 to 'Abnehmen' is marketing-driven, not evidence-based. For weight loss, focus on well-established genetic markers (e.g., FTO, MC4R) and lifestyle factors.